2-Imidazolines. IV . 1-Aryl-2-alkylthio-4,5- diamino-4,5-dihydroimidazoles. Synthesis and properties

1,2-Diimmonium salts ( 1 ) react with S-substituted isothioureas ( 3 ) yielding 2-alkylthio-4,5-diamino-4,5-dihydroimidazoles ( 4 ), which under mild pyrolytic conditions afforded 2-alkylthio-5-aminoimidazoles ( 7 ). Imidazolines ( 4 ) and imidazoles ( 7 ) were easily desulfurated with Raney nickel affording 4,5-diamino-4,5-dihydroimidazole ( 9 ) and 5-aminoimidazole ( 10 ), respectively.     

Application of Organolithium and Related Reagents in Synthesis. XV. A Concise Regiospecific Conversion of Picolinic- and Isonicotinic Acids into 2-Benzoyl- and 4-Benzoylnicotinic Acids

The synthesis of the azaphthalides (7) and (8) and their conversion into the corresponding 2- and 4-benzoyl-3-hydroxymethylpyridines (9) and (10), very useful precursors of the 2- and 4-benzoylated nicotinic acids (11) and (12), as a way of regiospecific transformation of the picolin- and isonicotinanilides (1) and (2) Into nicotinic acid derivatives, is described.     

Synthesis, structure, and magnetic properties of (6-9)-nuclear Ni(II) trimethylacetates and their heterospin complexes with nitroxides

New polynuclear nickel trimethylacetates [Ni6(OH)4(C5H9O2)8(C5H10O2)4] (6), [Ni7(OH)7(C5H9O2)7(C5H10O2)6(H2O)] x 0.5 C6H14 x 0.5 H2O (7), [Ni8(OH)4(H2O)2(C5H9O2)12] (8), and [Ni9(OH)6(C5H9O2)12(C5H10O2)4] x C5H10O2 x 3 H2O (9), where C5H9O2 is trimethylacetate and C5H10O2 is trimethylacetic acid, have been found. Their structures were determined by X-ray crystallography. Because of their high solubility in low-polarity organic solvents, compounds 6-9 reacted with stable organic radicals to form the first heterospin compounds based on polynuclear Ni(II) trimethylacetate and nitronyl nitroxides containing pyrazole (L(1)-L(3)), methyl (L(4)), or imidazole (L(5)) substituent groups, respectively, in side chain [Ni7(OH)5(C5H9O2)9(C5H10O2)2(L(1))2(H2O)] x 0.5 C6H14 x H2O (6+1a), [Ni7(OH)5(C5H9O2)9(C5H10O2)2(L2)2(H2O)] x H2O (6+1b), [Ni7(OH)5(C5H9O2)9(C5H10O2)2(L(3))2(H2O)] x H2O (6+1c), [Ni6(OH)3(C5H9O2)9(C5H10O2)4(L(4))] x 1.5 C6H14 (6'), and [Ni4OH)3(C5H9O2)5(C5H10O2)4(L(5))] x 1.5 C7H8 (4). Their structures were also determined by X-ray crystallography. Although Ni(II) trimethylacetates may have varying nuclearity and can change their nuclearity during recrystallization or interactions with nitroxides, this family of compounds is easy to study because of its topological relationship. For any of these complexes, the polynuclear framework may be derived from the [Ni6] polynuclear fragment {Ni6(mu4-OH)2(mu3-OH)2(mu2-C5H9O2-O,O')6(mu2-C5H9O2-O,O)(mu4-C5H9O2-O,O,O',O')(C5H10O2)4}, which is shaped like an open book. On the basis of this fragment, the structure of 7-nuclear compounds (7 and 6+1a-c) is conveniently represented as the result of symmetric addition of other mononuclear fragments to the four Ni(II) ions lying at the vertexes of the [Ni6] open book. The 9-nuclear complex is formed by the addition of trinuclear fragments to two Ni(II) ions lying on one of the lateral edges of the [Ni6] open book. This wing of the 9-nuclear complex preserves its structure in another type of 6-nuclear complex (6') with the boat configuration. If, however, two edge-sharing Ni(II) ions are removed from [Ni6] (one of these lies at a vertex of the open book and the other, on the book-cover line), we obtain a 4-nuclear fragment recorded in the molecular structure of 4. Twinning of this 4-nuclear fragment forms highly symmetric molecule 8, which is a new chemical version of cubane.     

Steroidal saponins and alkaloids from the bulbs of Lilium brownii var. colchesteri

The fresh bulbs of Lilium brownii var. colchesteri were found to contain five steroidal saponins: 26-O-beta-D-glucopyranosylnuatigenin 3-O-alpha-L-rhamnopyranosyl-(1----2)-beta-D-glucopyranoside (6), 26-O-beta-D-glucopyranosylnuatigenin 3-O-alpha-L-rhamnopyranosyl-(1----2)-O-[beta-D-glucopyranosyl-(1----4)]- beta-D-glucopyranoside (7), brownioside (8), deacylbrownioside (9) and 27-O-(3-hydroxy-3-methylglutaroyl)isonarthogenin 3-O-alpha-L-rhamnopyranosyl-(1----2)-O-[beta-D-glucopyranosyl-(1----4)- beta-D-glucopyranoside (10); and two steroidal alkaloids: beta 1-solamargine (11) and solasodine 3-O-alpha-L-rhamnopyranosyl-(1----2)-O-[beta-D-glucopyranosyl-(1----4)- beta-D-glucopyranoside (12); along with several phenolic constituents. Compounds 7, 10 and 12 are new naturally-occurring compounds.     

Photochemische Reaktionen. 98. Mitteilung. Photochemistry of N-Acylimidazoles. III. Rates and Yields of N→C Acyl Migration and of C(α)-C(β) Cleavage of Acyl Side Chains

Relative rates of the photoreactions of 1-( 1 ), 2-( 2 ) and 4(5)-valerylimidazole ( 3 ) as well as the yields of photo-fragmentation product 10 from 1-( 7 ), 2-( 8 ) and 4(5)-stearoylimidazole ( 9 ), respectively, were determined. A reaction path via Norrish Type II fragmentation involving the carbonyl group of 1-acylimidazoles was ruled out.     

Photoelectron Spectra of Unsaturated Oxides. I. 1,4-Dioxin and related systems

The He (Iα) photoelectron spectra of the four unsaturated oxides 3,4-dihydropyran ( 6 ), γ-pyran ( 7 ), 2, 3-dihydro-1, 4-dioxin ( 9 ) and 1, 4-dioxin ( 10 ) are reported and analysed. Band assignments are based on ab-initio calculations, using the STO-3G basis set. The proposed orbital sequences (with reference to the coordinate systems given in Table 1) are, for the top three orbitals: 6 , π, nσ, nπ; 7 , 3b₁(π), 1a₂(π), 11a₁(σ); 9 , 11b(π), 12a(σ), 11a(π); 10 , 2b_3u(π), 1b_1g(π), 6a_g(σ). Finally the (almost) localized π-orbitals have been computed by the Foster-Boys localization procedure.     

A novel isomerization on interaction of antitumor-active azole-bridged dinuclear platinum(II) complexes with 9-ethylguanine. Platinum(II) atom migration from N2 to N3 on 1,2,3-triazole

The reactions of the dinuclear platinum(II) complexes, [[cis-Pt(NH(3))(2)](2)(mu-OH)(mu-pz)](NO(3))(2) (1, pz = pyrazolate), [[cis-Pt(NH(3))(2)](2)(mu-OH)(mu-1,2,3-ta-N1,N2)](NO(3))(2) (2, 1,2,3-ta = 1,2,3-triazolate), and a newly prepared [[cis-Pt(NH(3))(2)](2)(mu-OH)(mu-4-phe-1,2,3-ta-N1,N2)](NO(3))(2) (3, 4-phe-1,2,3-ta = 4-phenyl-1,2,3-triazolate), whose crystal structure was determined, with 9-ethylguanine (9EtG) have been monitored in aqueous solution at 310 K by means of (1)H NMR spectroscopy. The dinuclear platinum(II) complexes 1-3 each react with 9EtG in a bifunctional way to form 1:2 complexes, [[cis-Pt(NH(3))(2)(9EtG-N7)](2)(mu-pz)](3+) (4), [[cis-Pt(NH(3))(2)(9EtG-N7)](2)(mu-1,2,3-ta-N1,N3)](3+) (5), and [[cis-Pt(NH(3))(2)(9EtG-N7)](2)(mu-4-phe-1,2,3-ta-N1,N3)](3+) (6). The reactions of 2 and 3 involve a novel isomerization, in which the Pt atom, initially bound to N2 on the 1,2,3-ta, migrates to N3 after the first substitution by N7 of 9EtG. This isomerization reaction has been unambiguously characterized by 1D and 2D NMR spectroscopy and pH titration. The reactions of 2 and 3 with 9EtG show faster kinetics, and the second-order rate constants (k) for the reactions of 1-3are 1.57 x 10(-4), 2.53 x 10(-4), and 2.56 x 10(-4) M(-1) s(-1), respectively. The pK(a) values at the N1H site of 9EtG were determined for 4-6 from the pH titration curves. Cytotoxicity assays of 1-3 were performed in L1210 murine leukemia cell lines, respectively sensitive and resistant to cisplatin. In the parent cell line, 2 and 3 exhibit higher cytotoxicity compared to cisplatin, especially, 2 is 10 times as active as cisplatin. 1 was found to be less cytotoxic than cisplatin, but still in the active range and more active than cisplatin in a cisplatin-resistant cell line.     

Addition of the phenoxathiin cation radical to alkenes and nonconjugated dienes. Formation of (E)- and (Z)-(10-phenoxathiiniumyl)alkenes and (E)- and (Z)-(10-phenoxathiiniumyl)dienes on basic alumina

Addition of phenoxathiin cation radical (PO*+) to acyclic alkenes in acetonitrile (MeCN) solution occurred stereospecifically to form bis(10-phenoxathiiniumyl)alkane adducts. Stereospecific trans addition is ascribed to the intermediacy of an episulfonium cation radical. The alkenes used were cis- and trans-2-butene, cis- and trans-2-pentene, cis- and trans-4-methyl-2-pentene, cis- and trans-4-octene, trans-3-hexene, trans-3-octene, trans-5-decene, cis-2-hexene, and cis-2-heptene. The erythro bisadducts (compounds 6) were obtained with trans-alkenes, while threo bisadducts (compounds 7) were obtained with cis-alkenes. The assigned structures of 6 and 7 were consistent with their NMR spectra and, in one case, 6c (the adduct of trans-4-methyl-2-pentene) was confirmed with X-ray crystallography. Additions of PO*+ to 1,4-hexa-, 1,5-hexa-, 1,6-hepta-, and 1,7-octadiene gave bis(10-phenoxathiiniumyl)alkenes (compounds 8), the assigned structures of which were consistent with their NMR spectra. Each of these adducts lost a proton and phenoxathiin (PO) when treated with basic alumina in MeCN solution. Compounds 6 (from trans-alkenes) gave mixtures of (Z)- (9) and (E)-(10-phenoxathiiniumyl)alkenes (10) in which the (Z)-isomers (9) were dominant. On the other hand, compounds 7 (from cis-alkenes) gave mixtures of 9 and 10 in which, with one exception (the adduct 7c of cis-4-methyl-2-pentene), compounds 10 were dominant. The path to elimination is discussed. The alkenes 9 and 10 were characterized with NMR spectroscopy and, in one case (9a), with X-ray crystallography. Reactions of 8b-d with basic alumina gave mixtures of (E)- (13) and (Z)-(10-phenoxathiiniumyl)dienes (14), in which compounds 13 were dominant. The configuration of the product from 8a (the adduct of 1,4-hexadiene) could not be settled. Noteworthy features in the coupling patterns and chemical shifts in the NMR spectra of some of the adducts and their products are discussed and related to adduct conformations.     

Polynucleotide analogues. VI. Synthesis and characterization of alternating copolymers of maleic anhydride and dihydropyran containing guanine derivatives

2-Amino-6-chloropurine was reacted with 2-(tosyloxymethyl)-2,3-dihydro-2H-pyran to give 2-(2-amino-6-chloropurin-9-ylmethyl)-2,3-dihydro-2H-pyran ( 3 ) and its N⁷-isomer ( 4 ), which were treated with 5% aqueous trimethylamine to result in 2-(guanin-9-ylmethyl)-2,3-dihydro-2H-pyran ( 5 ) and its N⁷-isomer ( 6 ), respectively. 2-(N²-Acetylguanin-9-yl-methyl)-3,4-dihydro-2H-pyran ( 7 ) and 2-(N²-acetylguanin-7-ylmethyl)-3,4-dihydro-2H-pyran ( 8 ), obtained by acetylation of compounds 5 and 6 , were copolymerized with maleic anhydride to give the alternating copolymers 9 and 10 , and they were hydrolyzed to result in poly[ {2-(guanin-9-ylmethyl)tetrahydropyran-5,6-diyl} {1,2-dicarboxyethylene}] ( 11 ) and poly[ {2-(guanin-7-ylmethyl)tetrahydropyran-5,6-diyl} {1,2-dicarboxyethylene}] ( 12 ), re-spectively. Polymer 11 showed hypochromicity whereas 12 exhibited hyperchromicity in aqueous solutions. Polymers 11 and 12 in aqueous solutions showed very strong excimer fluorescence with the maximum intensities at 432 and 446 nm, respectively, at room tem-perature. The two polymers showed polyelectrolyte effects, e.g., very high GPC molecular weights as well as reduced viscosities at low concentrations in water. Normal behavior was retained by addition of inorganic salts. Sodium salts of polymers 11 and 12 migrated to the anode by electrophoresis and both showed two bands. © 1995 John Wiley & Sons, Inc.     

Polyhedral monocarbaborane chemistry. Some C-phenylated seven, eight, nine, ten, eleven and twelve-vertex species

Some synthetic and structural systematics for monocarbaboranes, using the C-phenylated motif as the example, are investigated. The 10-vertex [6-Ph-nido-6-CB(9)H(11)](-) anion 1, from reaction of PhCHO with B(10)H(14) in KOH/H(2)O, is a useful entry synthon into C-phenyl monocarbaborane chemistry. Treatment of anion 1 with Na/thf yields the 10-vertex [1-Ph-closo-1-CB(9)H(9)](-) anion 2a, whereas treatment of anion 1 with iodine in alkaline solution yields the isomeric 10-vertex [2-Ph-closo-2-CB(9)H(9)](-) anion 2b, which isomerises quantitatively to 2a on heating under reflux in DME. Thermolysis of anion 1 yields the 9-vertex [4-Ph-closo-4-CB(8)H(8)](-) anion 5, whereas treatment of anion 1 with FeCl(3)/HCl gives neutral 9-vertex [4-Ph-arachno-4-CB(8)H(13)] 3. Compound 3 gives neutral 9-vertex [1-Ph-nido-1-CB(8)H(11)] 4 in refluxing toluene, and gives the 7-vertex [2-Ph-closo-2-CB(6)H(6)](-) anion 7 and the 8-vertex [1-Ph-closo-1-CB(7)H(7)](-) anion 6 in refluxing toluene with NEt(3). Reaction of 1 with [BH(3)(thf)] yields the 11-vertex [7-Ph-nido-7-CB(10)H(12)](-) anion 8 which can be converted to the 12-vertex [1-Ph-closo-1-CB(11)H(11)](-) anion 10 using [BH(3)(SMe(2))]; alternatively, anion 1 yields anion 10 directly on treatment with [BH(3)(NEt(3))]. Treatment of anion 8 with I(2)/KOH yields the 11-vertex [2-Ph-closo-2-CB(10)H(10)](-) anion 9. The structures of anions 1, 2a, 2b, 5, 6, 7, 8, 9 and 10 have been established by single-crystal X-ray diffraction analyses of their [NEt(4)](+) salts, and those of neutral 3 and 4 estimated by DFT calculations at the B3LYP/6-31G* level; similar calculations have also been applied to the new anionic closo species 2a, 2b, 5, 6, 7, 9 and 10. Crystals of the [NEt(4)](+) salt of the [2-Ph-closo-2-CB(6)H(6)](-) anion 7 required synchrotron X-radiation for sufficient diffraction intensity for molecular-structure elucidation. The syntheses are in principle generally applicable to give extensive derivative C-aryl and C-alkyl chemistries.     

Purines. LII. Synthesis and biological evaluation of 8-methylguanine 7-oxide and its 9-arylmethyl derivatives.

The synthesis of 8-methylguanine 7-oxide (3) was accomplished via a "phenacylamine route", which started from condensation of alpha-(4-methoxybenzylamino)propiophenone (6), prepared by coupling of alpha-bromopropiophenone (4) and 4-methoxybenzylamine (5), with 2-amino-6-chloro-5-nitro-4(3H)-pyrimidinone (7) and proceeded through cyclization of the resulting phenacylaminopyrimidinone (8) and removal of the 4-methoxybenzyl group. The N-oxide 3 and its 9-arylmethyl derivatives 9 and 11 showed only very weak antileukemic activity and no antimicrobial activity.     

New chemistry of 1,2-closo-P2B10H10 and 1,2-closo-As2B10H10; in silico and gas electron diffraction structures, and new metalladiphospha- and metalladiarsaboranes

The molecular structures of 1,2-closo-P(2)B(10)H(10) (1) and 1,2-closo-As(2)B(10)H(10) (2) have been determined by gas electron diffraction and the results obtained compared with those from computation at the MP2/6-31G** level of theory. The level of agreement is good for 2 (root-mean-square [rms] misfit for As and B atoms 0.0297 ?) and very good for 1 (rms misfit for P and B atoms 0.0082 ?). In comparing the structures of 1 and 2 with that of 1,2-closo-C(2)B(10)H(12) (I) it is evident that expansion of the polyhedron from I to 1 to 2 is restricted only to the heteroatom vertices and the B(6) face to which these are bound. Following deboronation (at B3) and subsequent metallation, compounds 1 and 2 have been converted into the new metalladiheteroboranes 3-(η-C(9)H(7))-3,1,2-closo-CoAs(2)B(9)H(9) (4), 3-(η-C(10)H(14))-3,1,2-closo-RuAs(2)B(9)H(9) (5), 3-(η-C(5)H(5))-3,1,2-closo-CoP(2)B(9)H(9) (6), 3-(η-C(9)H(7))-3,1,2-closo-CoP(2)B(9)H(9) (7) and 3-(η-C(10)H(14))-3,1,2-closo-RuP(2)B(9)H(9) (8), the last three constituting the first examples of metalladiphosphaboranes. Together with the known compound 3-(η-C(5)H(5))-3,1,2-closo-CoAs(2)B(9)H(9) (3), compounds 4-8 have been analysed by NMR spectroscopy and (except for 8) single-crystal X-ray diffraction. The (11)B NMR spectra of analogous pairs of metalladiphosphaborane and metalladiarsaborane (6 and 3, 7 and 4, 8 and 5) reveal a consistently narrower (9-10 ppm) chemical shift range for the metalladiarsaboranes, the combined result of a deshielding of the lowest frequency resonance (B6) and an increased shielding of the highest frequency resonance (B8) via an antipodal effect. In crystallographic studies, compounds 3 and 5B (one of two crystallographically-independent molecules) suffer As/B disorder, but in both cases it was possible to refine distinct, ordered, components of the disorder, the first time this has been reported for metalladiarsaboranes. Moreover, whilst the Cp compounds 6 and 3 are disordered, their indenyl analogues 7 and 4 are either ordered or significantly less disordered, a consequence of both the reduced symmetry of an indenyl ligand compared to a Cp ligand and the preference of the former for a distinct conformation relative to the cage heteroatoms. Unexpectedly, whilst this conformation in the cobaltadiphosphaborane 7 is cis-staggered (similar to that previously established for the analogous cobaltadicarborane), in the cobaltadiarsaborane 4 the conformation is close to cis-eclipsed.     

Two new podophyllotoxin glucosides from Sinopodophyllum emodi (Wall.) Ying.

Two new aryltetralin-type lignans, isopodophyllotoxin 7'-O-beta-D-glucopyranosyl-(1-->6)-beta-D-glucopyranoside (1) and 4-demethyl-picropodophyllotoxin 7'-O-beta-D-glucopyranoside (2), along with eight known podophyllotoxin derivatives: 4-demethyl-podophyllotoxin 7'-O-beta-D-glucopyranoside (3), podophyllotoxin 7'-O-beta-D-glucopyranoside (4), deoxypodophyllotoxin (5), picropodophyllotoxin (6), podophyllotoxin (7), 4-demethyl-picropodophyllotoxin (8), 4-demethyl-podophyllotoxin (9), and 4-demethyl-deoxypodophyllotoxin (10), were isolated from the roots and rhizomes of Sinopodophyllum emodi (Wall.) Ying (Berberidaceae). Their structures were identified based on NMR spectral data and chemical evidence.     

Syntheses and structures of heterometallic clusters by the reaction of o-carboranyl cobaltadichalcogenolato complexes

Metalladichalcogenolate cluster complexes [Cp'Co{E(2)C(2)(B(10)H(10))}]{Co2(CO)5} [Cp' = eta5-C5H5, E = S(3a), E = Se(3b); Cp' = eta5-C5(CH3)5, E = S(4a), E = Se(4b)], {CpCo[E(2)C(2)(B(10)H(10))]}(2)Mo(CO)2] [E = S(5a), Se(5b)], Cp*Co(micro2-CO)Mo(CO)(py)2[E(2)C(2)(B(10)H(10))] [E = S(6a), Se(6b)], Cp*Co[E(2)C(2)(B(10)H(10))]Mo(CO)2[E(2)C(2)(B(10)H(10))] [E = S(7a), Se(7b)], (Cp'Co[E(2)C(2)(B(10)H(10))]W(CO)2 [E(2)C(2)(B(10)H(10))] [Cp' = eta5-C5H5, E = S(8a), E = Se(8b); Cp' = eta5-C5(CH3)5, E = S(9a), E = Se(9b)], {CpCo[E(2)C(2)(B(10)H(10))]}(2)Ni [E = S(10a), Se(10b)] and 3,4-(PhCN(4)S)-3,1,2-[PhCN(4)SCo(Cp)S(2)]-3,1,2-CoC(2)B(9)H(8) 12 were synthesized by the reaction of [Cp'CoE(2)C(2)(B(10)H(10))] [Cp' = eta5-C5H5, E = S(1a), E = Se(1b); Cp' = eta5-C5(CH3)5, E = S(2a), E = Se(2b)] with Co2(CO)8, M(CO)3(py)3 (M = Mo, W), Ni(COD)2, [Rh(COD)Cl]2, and LiSCN4Ph respectively. Their spectrum analyses and crystal structures were investigated. In this series of multinuclear complexes, 3a,b and 4a,b contain a closed Co3 triangular geometry, while in complexes 5a-7b three different structures were obtained, the tungsten-cobalt mixed-metal complexes have only the binuclear structure, and the nickel-cobalt complexes were obtained in the trinuclear form. A novel structure was found in metallacarborane complex 12, with a B-S bond formed at the B(7) site. The molecular structures of 4a, 5a, 6a, 7b, 9a, 9b, 10a and 12 have been determined by X-ray crystallography.     

Cytotoxic compounds from the leaves of Gaillardia aristata Pursh. growing in Egypt

Ten compounds, neopulchellin (1), 6α- hydroxyneopulchellin (2), β-sitosterol-3-O-β-D-glucoside (3), apigenin (4), quercitin (5), eupafolin (6), kaempferol-3-methoxy-7-O-α-L-rhamnoside (7), apigenin-7-O-β-D-glucopyranoside (8), α-amyrin (9) and β-sitosterol (10), were isolated from the leaves of Gaillardia aristata by applying bioassay guided fractionation. The cytotoxicity was traced against two human cancer cell lines (breast (MCF7) and colon (HCT116)). The highest cytotoxicity was revealed by compounds 1 and 2 (isolated from chloroform extract); with IC(50) values of 0.43, 0.32?μg?mL(-1) against MCF7 and 0.46, 0.34?μg?mL(-1) against HCT116, respectively. Compounds 9 and 10 (isolated from the n-hexane extract) exhibited lower IC(50) values of 3.05, 2.35?μg?mL(-1) against MCF7 and 3.05, 2.35?μg?mL(-1) against HCT116, respectively, while compounds 4-7 obtained from the ethyl acetate extract revealed the lowest cytotoxicity. Identification of the aforementioned compounds was carried out on the basis of their physico-chemical properties and spectral analysis (UV, EI/MS, 1D and 2D).     

Synthesis and reactions of halo-, nitro-, and arylazo-substituted 3-acetyltropolones. Formation of heterocycle-fused troponoid compounds

3-Acetyltropolone ( 1 ) reacted with bromine, iodine, and nitric acid to afford respectively 3-acetyl-5,7-di-bromotropolone ( 2 ), 3-acetyl-7-iodotropolone ( 3 ), and 3-acetyl-5-nitro- ( 4 ) and 3-acetyl-5,7-dinitrotropolone ( 5 ). Azo-coupling reactions of 1 gave 3-acetyl-5-arylazotropolones 7a-f. The Schmidt reactions of 2 and 3 gave respectively 5,7-dibromo- ( 9 ) and 7-iodo-2-methyl-8H-cyclohept[d]oxazol-8-one ( 10 ), while 4 gave 3-acetamido-5-nitrotropolone ( 11 ). Compounds 2 and 4 reacted with hydroxylamine to give 3-methyl-8H-cyclohept[d]isoxazol-8-ones 12 and 13. The reactions of 2 , 3 , and 4 with hydrazine gave 3-methyl-1,8-dihydrocycloheptapyrazol-8-ones 15 , 16 , and 17.     

Synthesis of 6aλ4-thia-1,6-diselena-3,4-diazapentalenes, 1,6,6aλ4-triselena-3,4-diazapentalenes, 6aλ4-thia-1,3,4,6-tetraazapentalenes,and 6aλ4-Selena-1,3,4,6-tetraazapentalenes from cyclic thioureas and selenoureas

Imidazolidine-2-thione (7a) and the corresponding 2-selone (7b), hexahydropyrimidine-2-thione (7c) and 2-selone (7d), and hexahydro-1H-1,3-diazepine-2-thione (7e) and 2-selone (7f) reacted with 2,4-dinitrobenzyl chloride to give the 2-(2,4-dinitrobenzylthio) and 2-(2,4-dinitrobenzylseleno) derivatives (8a)-(8f) of 4,5-dihydroimidazolium chloride, 1,4,5,6-tetrahydropyr-imidinium chloride, and 4,5,6,7-tetrahydro-1H-1,3-diazepinium chloride. Deprotonation of the chlorides (8a)-(8f) gave, respectively, 2-(2,4-dinitrobenzylthio)-and 2-(2,4-dinitrobenzylseleno)-4,5-dihydroimidazole (9a) and (9b), 2-(2,4-dinitrobenzylthio)- and 2-(2,4-dinitrobenzylseleno)-1,4,5,6-tetrahydropyrimidine (9c) and (9d), and 2-(2,4-dinitrobenzylthio)- and 2-(2,4-dinitrobenzylseleno)-4,5,6,7-tetrahydro-1H-1,3-diazepine (9e) and (9f). The bases (9a)-(9f) reacted with isoselenocyanates with elimination of 2,4-dinitrotoluene and concomitant addition of two molecules of the isoselenocyanate to give 1,6,6aλ⁴-triheterapentalenes of two structural types, depending on the size of the heteroring in the bases (9a)-(9f). The imidazoles (9a) and (9b) gave 6aλ⁴-thia-1,6-diselena-3,4-diazapentalenes (10a)-(10j) and 1,6,6aλ⁴-triselena-3,4-diazapentalenes (11a)-(11h), respectively. The sulfur-containing bases (9c) and (9e) gave 6aλ⁴-thia-1,3,4,6-tetraazapentalenes (12a)-(12j) and (14a)-(14d), respectively, and the selenium-containing bases (9d) and (9f) gave 6aλ⁴-selena-1,3,4,6-tetraazapentalenes (13a)-(13j) and (15a)-(15d). Heteroatom-heteroatom covalent bond energies have been estimated for representative members of the series (10)-(14) by using the Huggins equation and experimentally determined bond lengths. © 1997 John Wiley & Sons, Inc.     

Studies on imidazole derivatives and related compounds. I. Synthesis of novel antineoplastic derivatives of 4-carbamoylimidazolium-5-olate

Acylation of 4-carbamoylimidazolium-5-olate ( 2 ) with a variety of acid chlorides produced 4(5)-carbamoyl-1H-imidazol-5-(4)yl acid carboxylates ( 3a-j ). Treatment of esters 3a,c with sodium hydroxide gave imides, 4a,c . Methylation of 3a and 2 with diazomethane gave the N-3 methyl derivative ( 6 ) and a mixture of the N-3, O-dimethyl derivative ( 9 ), the N-1, N-3-dimethyl derivative ( 10 ) and the O-methyl derivative ( 11 ), respectively. 5-Carbamoyl-1-methylimidazolium-4-olate ( 7 ) and its 4-carbamoyl isomer ( 16 ) were prepared from 2-aminopropanediamides 8 and 15 , respectively. Treatment of the imidazolium compound ( 10 ) with aqueous potassium hydroxide gave the recyclized product, 1-methyl-5-methylcarbamoylimidazolium 4-olate ( 18 ). Methyl derivatives 6, 7 , and 9 except 16 demonstrated the complete lack of antitumor activity against Lewis lung carcinoma or sarcoma 180 in mice.     

Alkaloid studies. VI. lithium aluminum hydride reduction of apoyohimbine and the synthesis of 3,4,5,6-tetradehydroyohimbane-16-methanols

Catalytic reduction of apoyohimbine ( 1 ), prepared from yohimbine and thionyl chloride in pyridine, gives methyl yohimbane-16α-carboxylate ( 2 ) after equilibration with methoxide. LAH reduction of 2 or β-yohimbine O-tosylate ( 3 ) gives yohimbane-16α-methanol ( 4a ). LAH reduction of 1 affords yohimbane-16α-carboxaldehyde ( 5 ), yohimb-16-ene-16-methanol ( 6a ) and yohimbane-16β-methanol ( 7a ). Structural assignments 6a and 7a are confirmed by mass spectral measurements. Pmr spectra of 4a, 6a and 7a and their O-acetates 4b, 6b and 7b are discussed. LAH reduction of apo-α-yohimbine ( 8 ) affords alloyohimb-16-ene-16-methanol ( 9 ). Dehydrogenation of 4a with palladium black and maleic acid gives 3,5,4,5,6-tetradehydroyohimbane-16α-methanol ( 10 ) iodide, and 7a gives 3,4,5,6-tetradehydroyohimbane-16β-methanol ( 11 ) iodide and picrate. Properties of 10 and 11 differ from those of melinonine E.     

Isolation and biological activity of new and known isolation and biological activity of new and known diterpenoids from Sideritis stricta Boiss. & Heldr

Nine known and one new ent-kaurene diterpenoid were isolated from the acetone extract of Sideritis stricta Boiss & Heldr. The new compound, identified as ent-1 beta-hydroxy-7 alpha-acetyl-15 beta,16 beta-epoxykaurane (1) by IR, 1D and 2D NMR techniques and mass spectra, was isolated along with sideroxol (2), 7-acetyl sideroxol (3), 7-epicandicandiol (4), linearol (5), ent-7 alpha,15 beta,18-trihydroxy-kaur-16-ene (6), ent-7 alpha-acetyl,15,18-dihydroxy-kaur-16-ene (7), foliol (8), sideridiol (9) and siderol (10). The antibacterial and antifungal activities of these compounds and the whole crude acetone extract were evaluated against E. coli, S. aureus, K. pneumeonia and C. albicans.